Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OmniAb (OABI) Cash & Equivalents (2021 - 2025)

OmniAb has reported Cash & Equivalents over the past 5 years, most recently at $25.5 million for Q4 2025.

  • Quarterly Cash & Equivalents rose 44.89% to $25.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.5 million through Dec 2025, up 44.89% year-over-year, with the annual reading at $25.5 million for FY2025, 44.89% up from the prior year.
  • Cash & Equivalents was $25.5 million for Q4 2025 at OmniAb, down from $28.5 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $33.4 million in Q4 2022 and troughed at $19847.0 in Q3 2022.
  • The 5-year median for Cash & Equivalents is $18.7 million (2024), against an average of $15.8 million.
  • Year-over-year, Cash & Equivalents plummeted 94.52% in 2022 and then skyrocketed 106943.89% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $362203.0 in 2021, then skyrocketed by 9118.59% to $33.4 million in 2022, then plummeted by 51.01% to $16.4 million in 2023, then rose by 7.69% to $17.6 million in 2024, then skyrocketed by 44.89% to $25.5 million in 2025.
  • Per Business Quant, the three most recent readings for OABI's Cash & Equivalents are $25.5 million (Q4 2025), $28.5 million (Q3 2025), and $18.3 million (Q2 2025).